The results showed that there was a significant positive correlation between MLH1, MSH2, MSH6, and PMS2 and MATL1 in PRAD, liver hepatocellular carcinoma (LIHC), lower grade glioma (LGG), and thyroid carcinoma (THCA) (Figure 7A). This evidence concerns the gene MLH1 and central nervous system cancer.